• Tenon Medical received a Nasdaq notice dated May 21, 2026, citing non-compliance with the $2.5 million minimum stockholders’ equity requirement under Listing Rule 5550(b)(1) for the quarter ended March 31, 2026.
• Stockholders’ equity was reported at $1.9 million, below the threshold, with the company also failing to meet alternative continued-listing standards tied to market value or net income.
• A compliance plan is due within 45 days, by July 6, 2026, with Nasdaq able to grant up to a 180-day extension from the notice date if the plan is accepted.
• Failure to submit an acceptable plan or regain compliance within any extension period could trigger a delisting notice, with an appeal to a Nasdaq hearings panel available to stay any suspension or delisting during the process.
• The notice does not immediately affect trading on the Nasdaq Capital Market.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenon Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-060662), on May 22, 2026, and is solely responsible for the information contained therein.